Xtandi: A Key Oncology Pillar in 2019
Pfizer or AstraZeneca: Which Is a Better Pick in April?(Continued from Prior Part)Xtandi’s growth trends According to Pfizer’s (PFE) fourth-quarter earnings conference call, Xtandi is a pillar of the company’s oncology business. In 2018, Pfizer